Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tumor Junction Burden and Antigen Presentation as Predictors of Survival in Mesothelioma Treated With Immune Checkpoint Inhibitors.
Kosari F, Disselhorst M, Yin J, Peikert T, Udell J, Johnson S, Smadbeck J, Murphy S, McCune A, Karagouga G, Desai A, Schaefer-Klein J, Borad MJ, Cheville J, Vasmatzis G, Baas P, Mansfield AS. Kosari F, et al. Among authors: mccune a. J Thorac Oncol. 2022 Mar;17(3):446-454. doi: 10.1016/j.jtho.2021.10.022. Epub 2021 Nov 17. J Thorac Oncol. 2022. PMID: 34800701 Free PMC article.
Composition, diversity and potential utility of intervention-naïve pancreatic cancer intratumoral microbiome signature profiling via endoscopic ultrasound.
Gleeson FC, Jeraldo P, Levy MJ, Murphy SJ, Mendes-Soares H, Karagouga G, Mccune AF, Garcia Garcia Deparedes A, Kipp BR, Song SD, Khanna S, Pardi DS, Chia N. Gleeson FC, et al. Among authors: mccune af. Gut. 2022 Feb;71(2):441-443. doi: 10.1136/gutjnl-2021-324031. Epub 2021 Mar 22. Gut. 2022. PMID: 33753418 No abstract available.
Epigenomics may begin to explain in vitro differential response to hypomethylating agents in MMR-D hypermethylated endometrial cancer.
El Khoury LY, Lin WH, Smadbeck JB, Barrett MT, Sadeghian D, McCune AF, Karagouga G, Cheville JC, Harris FR, Kinsella LM, Feathers RW, Schafer Klein JL, Walther-Antonio MR, Johnson SH, Penheiter AR, Cucinella G, Schivardi G, Bhagwate A, Borad MJ, Mansfield AS, Murphy SJ, Mariani A, Vasmatzis G, Anastasiadis PZ, Weroha SJ, Larish AM. El Khoury LY, et al. Among authors: mccune af. Epigenomics. 2023 Mar;15(5):283-292. doi: 10.2217/epi-2023-0026. Epub 2023 May 22. Epigenomics. 2023. PMID: 37212177
Dynamics and survival associations of T cell receptor clusters in patients with pleural mesothelioma treated with immunotherapy.
Desai AP, Kosari F, Disselhorst M, Yin J, Agahi A, Peikert T, Udell J, Johnson SH, Smadbeck J, Murphy S, Karagouga G, McCune A, Schaefer-Klein J, Borad MJ, Cheville J, Vasmatzis G, Baas P, Mansfield A. Desai AP, et al. Among authors: mccune a. J Immunother Cancer. 2023 Jun;11(6):e006035. doi: 10.1136/jitc-2022-006035. J Immunother Cancer. 2023. PMID: 37279993 Free PMC article. Clinical Trial.
Unraveling the genomic underpinnings of unbalanced MYC break-apart FISH results using whole genome sequencing analysis.
Gagnon MF, Penheiter AR, Harris F, Sadeghian D, Johnson SH, Karagouga G, McCune A, Zepeda-Mendoza C, Greipp PT, Xu X, Ketterling RP, McPhail ED, King RL, Peterson JF, Vasmatzis G, Baughn LB. Gagnon MF, et al. Among authors: mccune a. Blood Cancer J. 2023 Dec 19;13(1):190. doi: 10.1038/s41408-023-00967-8. Blood Cancer J. 2023. PMID: 38114462 Free PMC article. No abstract available.
Individualized Cell-Free DNA Monitoring With Chromosomal Junctions for Mesothelioma.
Parikh K, Harris FR, Karagouga G, Schrandt A, Mandrekar J, Johnson S, McCune A, Sadeghian D, Roy D, Polonis K, Gaitatzes A, Bungum AO, Edell ES, Borad MJ, Peikert T, Kosari F, Cheville J, Vasmatzis G, Mansfield AS. Parikh K, et al. Among authors: mccune a. JTO Clin Res Rep. 2024 May 18;5(12):100692. doi: 10.1016/j.jtocrr.2024.100692. eCollection 2024 Dec. JTO Clin Res Rep. 2024. PMID: 39735890 Free PMC article.
71 results